Sino Biopharmaceutical Limited (SBHMY)
USD 8.34
(0.0%)
USD 8.34
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.58 Billion CNY | -10.03% |
| 2022 | 13.98 Billion CNY | 15.39% |
| 2021 | 12.11 Billion CNY | -14.72% |
| 2020 | 14.2 Billion CNY | 64.93% |
| 2019 | 8.61 Billion CNY | 152.47% |
| 2018 | 3.41 Billion CNY | 15.64% |
| 2017 | 2.95 Billion CNY | -3.14% |
| 2016 | 3.04 Billion CNY | 110.8% |
| 2015 | 1.44 Billion CNY | 4.86% |
| 2014 | 1.37 Billion CNY | 2278.87% |
| 2013 | 57.94 Million CNY | 75.31% |
| 2012 | 33.05 Million CNY | -52.03% |
| 2011 | 68.9 Million CNY | -47.94% |
| 2010 | 132.34 Million CNY | 13132.37% |
| 2009 | 1 Million CNY | -98.89% |
| 2008 | 90 Million CNY | 64.64% |
| 2007 | 54.66 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | -100.0% |
| 2004 | 45.7 Million CNY | -45.04% |
| 2003 | 83.16 Million CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | -100.0% |
| 2000 | 25.53 Million CNY | -54.34% |
| 1999 | 55.92 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 9.51 Billion CNY | 1.74% |
| 2024 Q1 | 9.51 Billion CNY | -24.4% |
| 2023 Q3 | 12.64 Billion CNY | 9.44% |
| 2023 Q4 | 12.58 Billion CNY | -0.51% |
| 2023 Q2 | 11.55 Billion CNY | 0.33% |
| 2023 FY | 12.58 Billion CNY | -10.03% |
| 2023 Q1 | 11.51 Billion CNY | -17.63% |
| 2022 Q3 | 14.05 Billion CNY | 16.98% |
| 2022 FY | 13.98 Billion CNY | 15.39% |
| 2022 Q4 | 13.98 Billion CNY | -0.54% |
| 2022 Q1 | 11.96 Billion CNY | -1.24% |
| 2022 Q2 | 12.01 Billion CNY | 0.41% |
| 2021 Q4 | 12.11 Billion CNY | -0.59% |
| 2021 FY | 12.11 Billion CNY | -14.72% |
| 2021 Q1 | 13.8 Billion CNY | -2.84% |
| 2021 Q3 | 12.18 Billion CNY | -10.72% |
| 2021 Q2 | 13.65 Billion CNY | -1.11% |
| 2020 Q3 | 14.28 Billion CNY | -3.28% |
| 2020 FY | 14.2 Billion CNY | 64.93% |
| 2020 Q1 | 13.99 Billion CNY | 62.42% |
| 2020 Q2 | 14.76 Billion CNY | 5.51% |
| 2020 Q4 | 14.2 Billion CNY | -0.49% |
| 2019 Q1 | 3.35 Billion CNY | -1.72% |
| 2019 Q2 | 3.26 Billion CNY | -2.59% |
| 2019 Q4 | 8.61 Billion CNY | 156.67% |
| 2019 FY | 8.61 Billion CNY | 152.47% |
| 2019 Q3 | 3.35 Billion CNY | 2.74% |
| 2018 Q4 | 3.41 Billion CNY | -4.1% |
| 2018 Q3 | 3.55 Billion CNY | 8.05% |
| 2018 Q2 | 3.29 Billion CNY | 7.14% |
| 2018 Q1 | 3.07 Billion CNY | 4.16% |
| 2018 FY | 3.41 Billion CNY | 15.64% |
| 2017 Q2 | 2.63 Billion CNY | -8.05% |
| 2017 Q4 | 2.95 Billion CNY | -1.72% |
| 2017 FY | 2.95 Billion CNY | -3.14% |
| 2017 Q1 | 2.86 Billion CNY | -6.08% |
| 2017 Q3 | 3 Billion CNY | 14.12% |
| 2016 Q1 | 1.44 Billion CNY | 0.1% |
| 2016 FY | 3.04 Billion CNY | 110.8% |
| 2016 Q4 | 3.04 Billion CNY | 37.89% |
| 2016 Q3 | 2.2 Billion CNY | 49.38% |
| 2016 Q2 | 1.47 Billion CNY | 2.24% |
| 2015 FY | 1.44 Billion CNY | 4.86% |
| 2015 Q1 | 1.47 Billion CNY | 7.14% |
| 2015 Q2 | 1.47 Billion CNY | 0.02% |
| 2015 Q3 | 1.42 Billion CNY | -3.85% |
| 2015 Q4 | 1.44 Billion CNY | 1.77% |
| 2014 Q3 | 1.07 Billion CNY | -1.96% |
| 2014 FY | 1.37 Billion CNY | 2278.87% |
| 2014 Q4 | 1.37 Billion CNY | 28.05% |
| 2014 Q1 | 266 Million CNY | 359.07% |
| 2014 Q2 | 1.09 Billion CNY | 312.76% |
| 2013 FY | 57.94 Million CNY | 75.31% |
| 2013 Q3 | 49.98 Million CNY | 38.26% |
| 2013 Q2 | 36.15 Million CNY | 0.33% |
| 2013 Q1 | 36.03 Million CNY | 9.03% |
| 2013 Q4 | 57.94 Million CNY | 15.92% |
| 2012 FY | 33.05 Million CNY | -52.03% |
| 2012 Q4 | 33.05 Million CNY | -83.01% |
| 2012 Q3 | 194.49 Million CNY | 15.93% |
| 2012 Q2 | 167.77 Million CNY | 0.0% |
| 2011 Q3 | 162.35 Million CNY | 6.73% |
| 2011 Q2 | 152.11 Million CNY | -23.34% |
| 2011 Q1 | 198.43 Million CNY | 0.0% |
| 2011 FY | 68.9 Million CNY | -47.94% |
| 2011 Q4 | 68.9 Million CNY | -57.56% |
| 2010 Q2 | 71.89 Million CNY | 0.0% |
| 2010 FY | 132.34 Million CNY | 13132.37% |
| 2009 FY | 1 Million CNY | -98.89% |
| 2009 Q4 | 1 Million CNY | 0.0% |
| 2008 FY | 90 Million CNY | 64.64% |
| 2007 FY | 54.66 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | -100.0% |
| 2004 FY | 45.7 Million CNY | -45.04% |
| 2003 FY | 83.16 Million CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | -100.0% |
| 2000 FY | 25.53 Million CNY | -54.34% |
| 1999 FY | 55.92 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -30432.35% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -305100.758% |
| SQZ Biotechnologies Company | 27.47 Million USD | -45694.634% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -28904.782% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -42162.187% |
| Mesoblast Limited | 118.7 Million USD | -10498.315% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -1326550.715% |
| Genus plc | 233.1 Million USD | -5296.93% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -429203.014% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -936219.873% |
| Marizyme, Inc. | 18.71 Million USD | -67111.156% |
| ContraFect Corporation | 2.88 Million USD | -436562.409% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -1677265.867% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -9285103.746% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -869711.155% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -540763.602% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -222230.491% |
| MultiCell Technologies, Inc. | 202.58 USD | -6210012734.436% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -21782.872% |
| EV Biologics, Inc. | 1.49 Million USD | -841528.07% |
| Q BioMed Inc. | 4.1 Million USD | -305990.077% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -37905.631% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -1996520.096% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -1024048.764% |
| Biomind Labs Inc. | 735.54 Thousand USD | -1710236.595% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | -7233.495% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -96693.482% |
| Skye Bioscience, Inc. | 4.61 Million USD | -272478.959% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -1416492.047% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -8889400.982% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -214174.419% |
| IMV Inc. | 28.88 Million USD | -43454.523% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -48914103.507% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -556947.017% |
| GB Sciences, Inc. | 1.75 Million USD | -714968.149% |
| Alpha Cognition Inc. | 1.22 Million USD | -1030753.215% |
| HST Global, Inc. | 98.31 Thousand USD | -12795233.557% |
| CSL Limited | 12.18 Billion USD | -3.261% |
| Halberd Corporation | 150 Thousand USD | -8386729.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -1262548.218% |
| Resverlogix Corp. | 6.49 Million USD | -193710.568% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -2634506.073% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -4921902.254% |
| argenx SE | 20 Million USD | -62801.22% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -27512.476% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -464337.925% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -123034071.149% |
| Genscript Biotech Corporation | 417.73 Million USD | -2911.511% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -6270707.912% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -524574.4% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -5486484.297% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -18498.04% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -415612.161% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -3497229.515% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -61786.285% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -8462668.577% |
| BioStem Technologies, Inc. | 4.71 Million USD | -266916.144% |
| ONE Bio Corp. | 19.71 Million USD | -63710.452% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -5028336.898% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -5057894.532% |
| Agentix Corp. | 50 Thousand USD | -25160388.0% |
| LadRx Corporation | 33.6 Thousand USD | -37434417.646% |
| Cell Source, Inc. | 9.25 Million USD | -135841.295% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1663504.53% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1663504.53% |
| NovAccess Global Inc. | 2.19 Million USD | -571760.465% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -177767.693% |
| Itoco Inc. | 228.37 Thousand USD | -5508442.454% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -5962807.453% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -252363.255% |
| Kadimastem Ltd | 891.22 Thousand USD | -1411466.09% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -3130489.848% |
| CytoDyn Inc. | 30.07 Million USD | -41728.182% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -2597599.697% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -3575387.073% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -160773.508% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -10269486.939% |
| Rebus Holdings, Inc. | 310 Thousand USD | -4058043.226% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -265570.429% |
| International Stem Cell Corporation | 4.17 Million USD | -301006.845% |
| Bioxytran, Inc. | 1.92 Million USD | -653419.169% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -20156348.176% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -576737.269% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -151177.585% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -146437.496% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -808669.774% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -4694020.896% |
| Neutra Corp. | 54.15 Thousand USD | -23229540.298% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -687345.027% |
| PureTech Health plc | 25.51 Million USD | -49211.085% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -1027507.974% |
| IXICO plc | 472.02 Thousand USD | -2665076.061% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -81057.629% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -20105.008% |
| CSL Limited | 12.18 Billion USD | -3.261% |
| Cellectis S.A. | 92.77 Million USD | -13459.73% |